Zdrowie i gospodarka · 06/10/2005

FDA Announces Draft Guidance for Implantable Cardioverter Defibrillators

The Food and Drug Administration (FDA) has released a draft guidance document outlining functional indications for implantable cardioverter defibrillators (ICDs) and the types of devices suitable for these indications, aiming to provide clearer labeling and promotion guidelines for ICDs and cardiac resynchronization therapy defibrillators (CRT/ICDs).